Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

A novel study aimed at disentangling the neurological underpinnings of depression shows that multiple brain profiles may ...

A new study reveals that the same clinical signs of depression may stem from different brain profiles, highlighting both ...

Studies have linked excessive screen time to mental health problems like depression in adolescents. | Neuroscience ...

Lower diversity in the oral microbiome was linked to higher depressive symptoms in a large U.S. sample, with especially ...

Discover 8 surprising reasons why depression can worsen even while taking medication, including lifestyle factors and medical ...

Learn to distinguish between depression and laziness with these 6 key signs that reveal when low motivation stems from mental ...

Are memory lapses a result of normal aging or symptoms of something more serious? Then, a closer look at a new device ...

Researchers followed thousands of pre-teens for three years, generating unique insights into how social media is shaping kids ...

Adults with treatment-resistant depression who received IV ketamine showed improvement in sadness-related symptoms ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...